Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Early outcomes using hepatitis C-positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies.

Schlendorf KH, Zalawadiya S, Shah AS, Wigger M, Chung CY, Smith S, Danter M, Choi CW, Keebler ME, Brinkley DM, Sacks SB, Ooi H, Perri R, Awad JA, Lewis S, Hayes R, O'Dell H, Darragh C, Carver A, Edmonds C, Ruzevich-Scholl S, Lindenfeld J.

J Heart Lung Transplant. 2018 Jun;37(6):763-769. doi: 10.1016/j.healun.2018.01.1293. Epub 2018 Jan 31.

PMID:
29530322
2.

Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin*.

Bräu N, Bini EJ, Currie S, Shen H, Schmidt WN, King PD, Ho SB, Cheung RC, Hu KQ, Anand BS, Simon FR, Aytaman A, Johnson DP, Awad JA, Ahmad J, Mendenhall CL, Pedrosa MC, Moseley RH, Hagedorn CH, Waters B, Chang KM, Morgan TR, Rossi SJ, Jeffers LJ, Wright TL; VA-HCV-001 Study Group.

J Viral Hepat. 2006 Apr;13(4):242-9.

PMID:
16611190
3.

Case of fulminant hepatic failure due to unrecognized peripartum cardiomyopathy.

Fussell KM, Awad JA, Ware LB.

Crit Care Med. 2005 Apr;33(4):891-3.

PMID:
15818120
4.

Urinary F2-isoprostanes in young healthy children at risk for type 1 diabetes mellitus.

Kauffman LD, Sokol RJ, Jones RH, Awad JA, Rewers MJ, Norris JM.

Free Radic Biol Med. 2003 Sep 15;35(6):551-7.

PMID:
12957647
5.

Validating methods of urine collection: a pilot study.

Seifert JA, Ross CA, Deutsch JC, Awad JA, Norris JM.

Urol Nurs. 2002 Apr;22(2):113-7.

PMID:
11993239
6.

Bromfenac (Duract)-associated hepatic failure requiring liver transplantation.

Hunter EB, Johnston PE, Tanner G, Pinson CW, Awad JA.

Am J Gastroenterol. 1999 Aug;94(8):2299-301.

PMID:
10445569
7.

Increased urinary F2-isoprostane excretion in alcoholic liver disease.

Hill DB, Awad JA.

Free Radic Biol Med. 1999 Mar;26(5-6):656-60.

PMID:
10218654
8.

The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation.

Morrow JD, Chen Y, Brame CJ, Yang J, Sanchez SC, Xu J, Zackert WE, Awad JA, Roberts LJ.

Drug Metab Rev. 1999 Feb;31(1):117-39. Review.

PMID:
10065368
9.

Identification of free radical formation and F2-isoprostanes in vivo by acute Cr(VI) poisoning.

Kadiiska MB, Morrow JD, Awad JA, Roberts LJ 2nd, Mason RP.

Chem Res Toxicol. 1998 Dec;11(12):1516-20.

PMID:
9860496
10.

Experience with neoral versus sandimmune in primary liver transplant recipients.

Pinson CW, Chapman WC, Wright JK, Hunter EB, Awad JA, Raiford DS, Payne JL, Geevarghese S, Blair TK, Van Buren DH.

Transpl Int. 1998;11 Suppl 1:S278-83.

PMID:
9664997
11.

Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo--effects of oxygen tension and glutathione.

Morrow JD, Roberts LJ, Daniel VC, Awad JA, Mirochnitchenko O, Swift LL, Burk RF.

Arch Biochem Biophys. 1998 May 1;353(1):160-71.

PMID:
9578611
12.

Is extracorporeal CO2 removal an option in the treatment of adult respiratory distress syndrome?

Deslauriers J, Awad JA.

Ann Thorac Surg. 1997 Dec;64(6):1581-2. No abstract available.

PMID:
9436538
13.

Nashville experience with liver transplantation in Veterans Administration patients.

Chapman WC, Wright JK, Awad JA, Hunter EB, Raiford DS, Blair TK, Pinson CW.

J Surg Res. 1997 Jan;67(1):79-83.

PMID:
9070186
14.

Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo.

Morrow JD, Awad JA, Wu A, Zackert WE, Daniel VC, Roberts LJ 2nd.

J Biol Chem. 1996 Sep 20;271(38):23185-90.

15.

Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma.

Stein CM, Tanner SB, Awad JA, Roberts LJ 2nd, Morrow JD.

Arthritis Rheum. 1996 Jul;39(7):1146-50.

PMID:
8670323
16.

Isoprostanes--prostaglandin-like compounds formed in vivo independently of cyclooxygenase: use as clinical indicators of oxidant damage.

Awad JA, Roberts LJ 2nd, Burk RF, Morrow JD.

Gastroenterol Clin North Am. 1996 Jun;25(2):409-27. Review.

PMID:
9229581
17.

Demonstration of halothane-induced hepatic lipid peroxidation in rats by quantification of F2-isoprostanes.

Awad JA, Horn JL, Roberts LJ 2nd, Franks JJ.

Anesthesiology. 1996 Apr;84(4):910-6.

PMID:
8638846
18.

Outcomes analysis for 50 liver transplant recipients: the Vanderbilt experience.

Payne JL, McCarty KR, Drougas JG, Chapman WC, Wright JK, Pinson NY, Beliles KE, Newsom VL, Hunter EB, Raiford DS, Awad JA, Burk RF, Donovan KL, Van Buren DH, Pinson CW.

Am Surg. 1996 Apr;62(4):320-5.

PMID:
8600857
19.

Excretion of F2-isoprostanes in bile: a novel index of hepatic lipid peroxidation.

Awad JA, Morrow JD.

Hepatology. 1995 Sep;22(3):962-8.

PMID:
7657304
20.

Liver and kidney necrosis in selenium-deficient rats depleted of glutathione.

Burk RF, Hill KE, Awad JA, Morrow JD, Lyons PR.

Lab Invest. 1995 Jun;72(6):723-30.

PMID:
7783430
21.

Purification, characterization, and N-terminal amino acid sequence of the adenylyl cyclase-activating protease from bovine sperm.

Adeniran AJ, Shoshani I, Minuth M, Awad JA, Elce JS, Johnson RA.

Biol Reprod. 1995 Mar;52(3):490-9.

PMID:
7756444
22.

Pathogenesis of diquat-induced liver necrosis in selenium-deficient rats: assessment of the roles of lipid peroxidation and selenoprotein P.

Burk RF, Hill KE, Awad JA, Morrow JD, Kato T, Cockell KA, Lyons PR.

Hepatology. 1995 Feb;21(2):561-9.

PMID:
7843731
23.

Pumpless respiratory assistance using a membrane oxygenator as an artificial placenta: a preliminary study in newborn and preterm lambs.

Awad JA, Cloutier R, Fournier L, Major D, Martin L, Masson M, Guidoin R.

J Invest Surg. 1995 Jan-Feb;8(1):21-30.

PMID:
7734429
24.
25.

Effect of selenium deficiency and glutathione-modulating agents on diquat toxicity and lipid peroxidation in rats.

Awad JA, Burk RF, Roberts LJ 2nd.

J Pharmacol Exp Ther. 1994 Sep;270(3):858-64.

PMID:
7932197
26.

Histopathologic findings in synthetic and biologic explanted grafts used in peripheral arterial reconstruction.

Wagner E, Guidoin R, Marois M, Mantovani D, Roy R, Ricci M, Marois Y, King MW, Gill F, Awad JA.

ASAIO J. 1994 Jul-Sep;40(3):M279-83.

PMID:
8555524
27.

Detection and localization of lipid peroxidation in selenium- and vitamin E-deficient rats using F2-isoprostanes.

Awad JA, Morrow JD, Hill KE, Roberts LJ 2nd, Burk RF.

J Nutr. 1994 Jun;124(6):810-6.

PMID:
8207538
28.

Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells.

DuBois RN, Tsujii M, Bishop P, Awad JA, Makita K, Lanahan A.

Am J Physiol. 1994 May;266(5 Pt 1):G822-7.

PMID:
8203528
30.

Effect of oxygen tension on the generation of F2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes.

Longmire AW, Swift LL, Roberts LJ 2nd, Awad JA, Burk RF, Morrow JD.

Biochem Pharmacol. 1994 Mar 29;47(7):1173-7.

PMID:
8161346
31.

Liver transplantation: results with Vanderbilt's first 25 liver recipients.

Drougas JG, Hunter EB, Raiford DS, Burk RF, Awad JA, Wright JK, Lopez RR, Donovan KL, Franks JJ, Thomas AT, et al.

J Tenn Med Assoc. 1994 Jan;87(1):7-10. No abstract available.

PMID:
8145559
32.
33.

Simplification of the mass spectrometric assay for the major urinary metabolite of prostaglandin D2.

Awad JA, Morrow JD, Roberts LJ 2nd.

J Chromatogr. 1993 Jul 23;617(1):124-8.

PMID:
8376525
34.

Marked overproduction of non-cyclooxygenase derived prostanoids (F2-isoprostanes) in the hepatorenal syndrome.

Morrow JD, Moore KP, Awad JA, Ravenscraft MD, Marini G, Badr KF, Williams R, Roberts LJ 2nd.

J Lipid Mediat. 1993 Mar-Apr;6(1-3):417-20.

PMID:
8358000
35.

Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma.

Awad JA, Morrow JD, Takahashi K, Roberts LJ 2nd.

J Biol Chem. 1993 Feb 25;268(6):4161-9.

36.

Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation.

Morrow JD, Awad JA, Kato T, Takahashi K, Badr KF, Roberts LJ 2nd, Burk RF.

J Clin Invest. 1992 Dec;90(6):2502-7.

37.

Transforming growth factor alpha protection against drug-induced injury to the rat gastric mucosa in vivo.

Romano M, Polk WH, Awad JA, Arteaga CL, Nanney LB, Wargovich MJ, Kraus ER, Boland CR, Coffey RJ.

J Clin Invest. 1992 Dec;90(6):2409-21.

38.

Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.

Morrow JD, Awad JA, Boss HJ, Blair IA, Roberts LJ 2nd.

Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10721-5.

39.

Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans.

Morrow JD, Awad JA, Oates JA, Roberts LJ 2nd.

J Invest Dermatol. 1992 May;98(5):812-5.

40.

Prolonged pumpless arteriovenous perfusion for carbon dioxide extraction.

Awad JA, Deslauriers J, Major D, Guojin L, Martin L.

Ann Thorac Surg. 1991 Apr;51(4):534-40.

PMID:
1901479
41.

Quantification of the major urinary metabolite of prostaglandin D2 by a stable isotope dilution mass spectrometric assay.

Morrow JD, Prakash C, Awad JA, Duckworth TA, Zackert WE, Blair IA, Oates JA, Roberts LJ 2nd.

Anal Biochem. 1991 Feb 15;193(1):142-8.

PMID:
2042739
42.

Effect of mucosal thickening near gastric carcinoma on the endoscopic diagnosis of malignancy.

Awad JA, Lee EY, Wang TC, Deschryver-Kecskemeti K, Clouse RE.

Dig Dis Sci. 1990 Mar;35(3):317-20.

PMID:
2307077
43.

Effect of diabetes on the healing process of synthetic grafts implanted in dogs: a preliminary study.

Awad JA, Guidoin RG, Hosseinzadeh M, Marois M, Martin L, Paradis R, Zingg W.

Biomaterials. 1989 Nov;10(9):590-7.

PMID:
2611307
44.

Expanded PTFE prostheses as arterial substitutes in humans: late pathological findings in 73 excised grafts.

Formichi MJ, Guidoin RG, Jausseran JM, Awad JA, Johnston KW, King MW, Eng P, Courbier R, Marois M, Rouleau C, et al.

Ann Vasc Surg. 1988 Jan;2(1):14-27.

PMID:
3228535
45.

Interactions of forskolin and adenylate cyclase. Effects on substrate kinetics and protection against inactivation by heat and N-ethylmaleimide.

Awad JA, Johnson RA, Jakobs KH, Schultz G.

J Biol Chem. 1983 Mar 10;258(5):2960-5. No abstract available.

46.

Activation of brain adenylate cyclase by a factor derived from bovine sperm.

Johnson RA, Awad JA, Jakobs KH, Schultz G.

FEBS Lett. 1983 Feb 7;152(1):11-6. No abstract available.

47.
49.

[Micro-emboli and the use of filters during extracorporeal circulation].

Guidoin RG, Morin PJ, Domurado D, Awad JA.

Union Med Can. 1975 Sep;104(9):1348-56. French. No abstract available.

PMID:
126515
50.

[Prolonged cardiorespiratory assistance. Pulmonary function before and after perfusion using an artificial lung with membranes].

Awad JA, Roy J, Brassard A, Guidoin R, Morin PJ.

Union Med Can. 1975 May;104(5):715-21. French. No abstract available.

PMID:
1136065

Supplemental Content

Support Center